You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes
|
|---|---|
| Published in |
Frontiers in oncology, November 2018
|
| DOI | 10.3389/fonc.2018.00517 |
| Pubmed ID | |
| Authors |
Fanny Onodi, Chahrazed Maherzi-Mechalikh, Alice Mougel, Nadine Ben Hamouda, Charlotte Taboas, Fabien Gueugnon, Thi Tran, Herve Nozach, Elodie Marcon, Alain Gey, Magali Terme, Ahmed Bouzidi, Bernard Maillere, Jérôme Kerzerho, Eric Tartour, Corinne Tanchot |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 33% |
| Switzerland | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 52 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 12 | 23% |
| Student > Ph. D. Student | 9 | 17% |
| Student > Bachelor | 6 | 12% |
| Student > Master | 5 | 10% |
| Professor | 2 | 4% |
| Other | 1 | 2% |
| Unknown | 17 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Immunology and Microbiology | 8 | 15% |
| Biochemistry, Genetics and Molecular Biology | 7 | 13% |
| Medicine and Dentistry | 6 | 12% |
| Agricultural and Biological Sciences | 4 | 8% |
| Chemistry | 4 | 8% |
| Other | 7 | 13% |
| Unknown | 16 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2018.
All research outputs
#20,014,336
of 25,461,852 outputs
Outputs from Frontiers in oncology
#9,370
of 22,544 outputs
Outputs of similar age
#261,717
of 355,299 outputs
Outputs of similar age from Frontiers in oncology
#100
of 233 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,544 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,299 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 233 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.